# Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients

Study · id `cardio:ct-nct01328912` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01328912](<https://clinicaltrials.gov/study/NCT01328912>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01328912

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 429 participants.

## Technical summary

Registry record NCT01328912. Randomized; quadruple masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2016-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 429 participants (enrolled count; ClinicalTrials.gov record NCT01328912, source copy `cardio:ctgov-nct01328912-2016-02-05`, retrieved 2026-10-26)
- Start date: 2012-02 (registry gives no type) (ClinicalTrials.gov record NCT01328912, source copy `cardio:ctgov-nct01328912-2016-02-05`, retrieved 2026-10-26)
- Primary completion: 2016-02 (actual) (ClinicalTrials.gov record NCT01328912, source copy `cardio:ctgov-nct01328912-2016-02-05`, retrieved 2026-10-26)
- Completion: 2016-02 (actual) (ClinicalTrials.gov record NCT01328912, source copy `cardio:ctgov-nct01328912-2016-02-05`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01328912, source copy `cardio:ctgov-nct01328912-2016-02-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01328912-2016-02-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients
- Condition: Death
- Condition: Stroke
- Condition: Low Cardiac Output Syndrome
- Condition: Myocardial Infarction
- Condition: Renal Failure
- Condition: Pulmonary Failure
- Intervention (Other): Remote ischemic preconditioning stimulus
- Intervention (Other): control
- Lead sponsor: Queen's University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Queen's University (`cardio:org-queen-s-university`)

## Provenance

Content hash: 9086a2db8d98524bda9139e0e8a032419105a6d19a079f68a6ac56772af9ff7c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
